Immuron to launch PROIBS® in the United States

Stock Information for Immuron Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Immuron Limited

Immuron Reports FY26 Preliminary Results
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live stream
Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00
Immuron Double Digit 3Q Sales Growth

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.